Shaving 10 Months Off Treatment Not Inferior Against Rifampin-Resistant TB Shaving 10 Months Off Treatment Not Inferior Against Rifampin-Resistant TB

A new study in patients with rifampin-resistant tuberculosis (TB) is providing the first strong evidence that the Bangladesh protocol for treating multidrug-resistant (MDR)-TB, which is used for 9 to 11 months, is not inferior to the standard regimen recommended by the World Health Organization, which requires treatment for 20 months.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news